Biology is strategic. New biotechnologies such as genetic and cell engineering; the application of AI and big data to biology; and the automation of lab and commercial scale biomanufacturing are on the precipice of transforming lives globally. They present a transformative health, social and economic opportunity. The technologies also pose real challenges about what is ethically acceptable and safe. This will be one of the most globally disruptive set of technologies of the next decade.

Australia and India have real capabilities in modern biotechnologies. Both have world leading biotech companies, strong research capabilities and huge untapped potential to use feedstocks for resilient manufacturing. It is potentially the critical and emerging technology of most collaborative promise for both countries. BiaSPARK will drive forward Australia-India innovation, research and regulation in biotechnology to ensure that both countries take advantage of the opportunity in front of them.

Our team will focus on the following activities to realise this mission:

1) Raising awareness of the strategic opportunity for Australia and India
2) Building deeper Australia-India networks through dialogues and other opportunities for collaboration
3) Producing policy analysis to assist government in taking advantage of this opportunity.

BiaSPARK is a project funded by the Australian Department of Foreign Affairs and Trade though the Australia-India Strategic and Technology Policy Initiative (SATPI). The views expressed on this page and BiaSPARK material are solely of the authors and do not necessarily reflect the views of the Department of Foreign Affairs and Trade.

BiaSPARK

Org chart

Teams

Offices

BiaSPARK

Org chart

Teams

Offices

Related companies